These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21045204)

  • 21. Expression of selected angiogenesis-related small microRNAs in patients with abnormally increased secretion of glucocorticoids.
    Kawa MP; Sobuś A; Litwińska Z; Osowicz-Korolonek L; Cymbaluk-Płoska A; Stecewicz I; Zagrodnik E; Romanowska H; Walczak M; Syrenicz A; Machaliński B
    Endokrynol Pol; 2019; 70(6):489-495. PubMed ID: 31909455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Not miR-ly small RNAs: big potential for microRNAs in therapy.
    Love TM; Moffett HF; Novina CD
    J Allergy Clin Immunol; 2008 Feb; 121(2):309-19. PubMed ID: 18269923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overview of MicroRNAs in Cardiac Hypertrophy, Fibrosis, and Apoptosis.
    Wang J; Liew OW; Richards AM; Chen YT
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27213331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNAs: a novel class of potential therapeutic targets for cardiovascular diseases.
    Pan ZW; Lu YJ; Yang BF
    Acta Pharmacol Sin; 2010 Jan; 31(1):1-9. PubMed ID: 19966833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The emerging role of microRNAs as a therapeutic target for cardiovascular disease.
    Seok HY; Wang DZ
    BioDrugs; 2010 Jun; 24(3):147-55. PubMed ID: 20462281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HDL and microRNA therapeutics in cardiovascular disease.
    Michell DL; Vickers KC
    Pharmacol Ther; 2016 Dec; 168():43-52. PubMed ID: 27595929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNAs as a therapeutic target for cardiovascular diseases.
    Mishra PK; Tyagi N; Kumar M; Tyagi SC
    J Cell Mol Med; 2009 Apr; 13(4):778-89. PubMed ID: 19320780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current attempts to implement microRNA-based diagnostics and therapy in cardiovascular and metabolic disease: a promising future.
    Thanikachalam PV; Ramamurthy S; Wong ZW; Koo BJ; Wong JY; Abdullah MF; Chin YH; Chia CH; Tan JY; Neo WT; Tan BS; Khan WF; Kesharwani P
    Drug Discov Today; 2018 Mar; 23(3):460-480. PubMed ID: 29107764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic microRNA strategies in human cancer.
    Li C; Feng Y; Coukos G; Zhang L
    AAPS J; 2009 Dec; 11(4):747-57. PubMed ID: 19876744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating microRNAs in cardiovascular diseases: from biomarkers to therapeutic targets.
    Wang F; Chen C; Wang D
    Front Med; 2014 Dec; 8(4):404-18. PubMed ID: 25445171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNAs as Candidate Drug Targets for Cardiovascular Diseases.
    Hang P; Guo J; Sun C; Du Z
    Curr Drug Targets; 2017; 18(4):463-472. PubMed ID: 26926467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of microRNAs in gynecological pathology.
    Gilabert-Estelles J; Braza-Boils A; Ramon LA; Zorio E; Medina P; Espana F; Estelles A
    Curr Med Chem; 2012; 19(15):2406-13. PubMed ID: 22455593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid Nanoparticles to Deliver miRNA in Cancer.
    Campani V; De Rosa G; Misso G; Zarone MR; Grimaldi A
    Curr Pharm Biotechnol; 2016; 17(8):741-9. PubMed ID: 27215371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNAs as Therapeutic Targets and Colorectal Cancer Therapeutics.
    Yamamoto H; Mori M
    Adv Exp Med Biol; 2016; 937():239-47. PubMed ID: 27573904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of microRNAs in cardiac hypertrophy and heart failure.
    Wang N; Zhou Z; Liao X; Zhang T
    IUBMB Life; 2009 Jun; 61(6):566-71. PubMed ID: 19472179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Critical roles of microRNAs in the pathogenesis of systemic sclerosis: New advances, challenges and potential directions.
    Miao CG; Xiong YY; Yu H; Zhang XL; Qin MS; Song TW; Du CL
    Int Immunopharmacol; 2015 Sep; 28(1):626-33. PubMed ID: 26241784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of microRNAs in stem/progenitor cells and cardiovascular repair.
    Jakob P; Landmesser U
    Cardiovasc Res; 2012 Mar; 93(4):614-22. PubMed ID: 22135162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miRNAs: roles and clinical applications in vascular disease.
    Jamaluddin MS; Weakley SM; Zhang L; Kougias P; Lin PH; Yao Q; Chen C
    Expert Rev Mol Diagn; 2011 Jan; 11(1):79-89. PubMed ID: 21171923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysregulation of endothelial colony-forming cell function by a negative feedback loop of circulating miR-146a and -146b in cardiovascular disease patients.
    Chang TY; Tsai WC; Huang TS; Su SH; Chang CY; Ma HY; Wu CH; Yang CY; Lin CH; Huang PH; Cheng CC; Cheng SM; Wang HW
    PLoS One; 2017; 12(7):e0181562. PubMed ID: 28727754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miRNA and vascular cell movement.
    Yue J
    Adv Drug Deliv Rev; 2011 Jul; 63(8):616-22. PubMed ID: 21241758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.